The US Food and Drug Administration on Monday announced it had approved a drug called Aduhelm to treat patients with Alzheimer’s, the first new medicine against the disease in almost two decades.
“Aduhelm is the first treatment directed at the underlying pathophysiology of Alzheimer’s disease, the presence of amyloid beta plaques in the brain,” said the FDA’s Patrizia Cavazzoni.
The approval goes against the recommendations of an independent expert panel who met last November and found insufficient evidence of the drug’s benefit.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Read More: World News